These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

360 related articles for article (PubMed ID: 16985228)

  • 21. Risks of Incident Cardiovascular Disease Associated With Concomitant Elevations in Lipoprotein(a) and Low-Density Lipoprotein Cholesterol-The Framingham Heart Study.
    Afshar M; Rong J; Zhan Y; Chen HY; Engert JC; Sniderman AD; Larson MG; Vasan RS; Thanassoulis G
    J Am Heart Assoc; 2020 Sep; 9(18):e014711. PubMed ID: 32892691
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Lipoprotein(a) concentrations, apolipoprotein(a) isoforms and clinical endpoints in haemodialysis patients with type 2 diabetes mellitus: results from the 4D Study.
    Kollerits B; Drechsler C; Krane V; Lamina C; März W; Dieplinger H; Ritz E; Wanner C; Kronenberg F;
    Nephrol Dial Transplant; 2016 Nov; 31(11):1901-1908. PubMed ID: 26754832
    [TBL] [Abstract][Full Text] [Related]  

  • 23. C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women.
    Ridker PM; Hennekens CH; Buring JE; Rifai N
    N Engl J Med; 2000 Mar; 342(12):836-43. PubMed ID: 10733371
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Low-Density Lipoprotein Cholesterol Corrected for Lipoprotein(a) Cholesterol, Risk Thresholds, and Cardiovascular Events.
    Willeit P; Yeang C; Moriarty PM; Tschiderer L; Varvel SA; McConnell JP; Tsimikas S
    J Am Heart Assoc; 2020 Dec; 9(23):e016318. PubMed ID: 33222611
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cardiovascular Disease, Mortality Risk, and Healthcare Costs by Lipoprotein(a) Levels According to Low-density Lipoprotein Cholesterol Levels in Older High-risk Adults.
    Zhao Y; Delaney JA; Quek RG; Gardin JM; Hirsch CH; Gandra SR; Wong ND
    Clin Cardiol; 2016 Jul; 39(7):413-20. PubMed ID: 27177347
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evaluation of C-reactive protein before and on-treatment as a predictor of benefit of atorvastatin: a cohort analysis from the Anglo-Scandinavian Cardiac Outcomes Trial lipid-lowering arm.
    Sever PS; Poulter NR; Chang CL; Thom SA; Hughes AD; Welsh P; Sattar N;
    J Am Coll Cardiol; 2013 Aug; 62(8):717-29. PubMed ID: 23948514
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Triglyceride-Rich Lipoprotein Cholesterol, Small Dense LDL Cholesterol, and Incident Cardiovascular Disease.
    Duran EK; Aday AW; Cook NR; Buring JE; Ridker PM; Pradhan AD
    J Am Coll Cardiol; 2020 May; 75(17):2122-2135. PubMed ID: 32354380
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cardiovascular events with increased lipoprotein-associated phospholipase A(2) and low high-density lipoprotein-cholesterol: the Veterans Affairs HDL Intervention Trial.
    Robins SJ; Collins D; Nelson JJ; Bloomfield HE; Asztalos BF
    Arterioscler Thromb Vasc Biol; 2008 Jun; 28(6):1172-8. PubMed ID: 18356553
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Apolipoprotein(a) size and lipoprotein(a) concentration and future risk of angina pectoris with evidence of severe coronary atherosclerosis in men: The Physicians' Health Study.
    Rifai N; Ma J; Sacks FM; Ridker PM; Hernandez WJ; Stampfer MJ; Marcovina SM
    Clin Chem; 2004 Aug; 50(8):1364-71. PubMed ID: 15155542
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Low plasma HDL-c, a vascular risk factor in high risk patients independent of LDL-c.
    Hajer GR; van der Graaf Y; Bots ML; Algra A; Visseren FL;
    Eur J Clin Invest; 2009 Aug; 39(8):680-8. PubMed ID: 19453647
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Circulating Branched-Chain Amino Acids and Incident Cardiovascular Disease in a Prospective Cohort of US Women.
    Tobias DK; Lawler PR; Harada PH; Demler OV; Ridker PM; Manson JE; Cheng S; Mora S
    Circ Genom Precis Med; 2018 Apr; 11(4):e002157. PubMed ID: 29572205
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Low-density lipoprotein cholesterol and non-high-density lipoprotein cholesterol and the incidence of cardiovascular disease in an urban Japanese cohort study: The Suita study.
    Okamura T; Kokubo Y; Watanabe M; Higashiyama A; Miyamoto Y; Yoshimasa Y; Okayama A
    Atherosclerosis; 2009 Apr; 203(2):587-92. PubMed ID: 18783774
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Genetically elevated lipoprotein(a) and increased risk of myocardial infarction.
    Kamstrup PR; Tybjaerg-Hansen A; Steffensen R; Nordestgaard BG
    JAMA; 2009 Jun; 301(22):2331-9. PubMed ID: 19509380
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of age, sex, and menopausal status on plasma lipoprotein(a) levels. The Framingham Offspring Study.
    Jenner JL; Ordovas JM; Lamon-Fava S; Schaefer MM; Wilson PW; Castelli WP; Schaefer EJ
    Circulation; 1993 Apr; 87(4):1135-41. PubMed ID: 8462142
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Lipoprotein(a) Interactions With Low-Density Lipoprotein Cholesterol and Other Cardiovascular Risk Factors in Premature Acute Coronary Syndrome (ACS).
    Afshar M; Pilote L; Dufresne L; Engert JC; Thanassoulis G
    J Am Heart Assoc; 2016 Apr; 5(4):. PubMed ID: 27108248
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Relationship of oxidized phospholipids and biomarkers of oxidized low-density lipoprotein with cardiovascular risk factors, inflammatory biomarkers, and effect of statin therapy in patients with acute coronary syndromes: Results from the MIRACL (Myocardial Ischemia Reduction With Aggressive Cholesterol Lowering) trial.
    Fraley AE; Schwartz GG; Olsson AG; Kinlay S; Szarek M; Rifai N; Libby P; Ganz P; Witztum JL; Tsimikas S;
    J Am Coll Cardiol; 2009 Jun; 53(23):2186-96. PubMed ID: 19497447
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prognostic value of elevated lipoprotein(a) in patients with acute coronary syndromes.
    Gencer B; Rigamonti F; Nanchen D; Vuilleumier N; Kern I; Aghlmandi S; Klingenberg R; Räber L; Auer R; Carballo D; Carballo S; Heg D; Windecker S; Lüscher TF; Matter CM; Rodondi N; Mach F
    Eur J Clin Invest; 2019 Jul; 49(7):e13117. PubMed ID: 30937890
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Association of a reduction in low-density lipoprotein cholesterol with incident cardiovascular and cerebrovascular events among people with type 2 diabetes mellitus.
    Li L; Ambegaonkar BM; Reckless JP; Jick S
    Eur J Prev Cardiol; 2014 Jul; 21(7):855-65. PubMed ID: 23460659
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Association of high-density lipoprotein cholesterol with coronary heart disease risk across categories of low-density lipoprotein cholesterol: the atherosclerosis risk in communities study.
    Muntner P; Lee F; Astor BC
    Am J Med Sci; 2011 Mar; 341(3):173-80. PubMed ID: 21042169
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Usefulness of Low-Density Lipoprotein Cholesterol and Non-High-Density Lipoprotein Cholesterol as Predictors of Cardiovascular Disease in Chinese.
    Gu X; Yang X; Li Y; Cao J; Li J; Liu X; Chen J; Shen C; Yu L; Huang J; Gu D
    Am J Cardiol; 2015 Oct; 116(7):1063-70. PubMed ID: 26250998
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.